David Arkowitz - 20 Nov 2025 Form 4 Insider Report for iBio, Inc. (IBIO)

Role
Director
Signature
/s/ Marc Banjak, Attorney-in-fact
Issuer symbol
IBIO
Transactions as of
20 Nov 2025
Net transactions value
$0
Form type
4
Filing time
24 Nov 2025, 16:05:28 UTC
Previous filing
02 Jul 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Arkowitz David Director C/O IBIO, INC., 11750 SORRENTO VALLEY, ROAD, SUITE 200, SAN DIEGO /s/ Marc Banjak, Attorney-in-fact 24 Nov 2025 0001296999

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IBIO Stock Option (right to buy) Award $0 +13,500 $0.000000 13,500 20 Nov 2025 Common Stock 13,500 $1.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These options vest pro rata on a monthly basis over twelve months commencing on the date of the grant.